Ay, what, can’t hear there’s too much noise
I can see Chris sitting at the head of the board room table saying to David and the team.
Well, after a few hard year’s work the clinical trials are done, labs are built, US sales team are selling. Why not take some well deserved profits and a couple of weeks off, because when you come back you’ve Cxcolorectal all good to go now too.
My only real desire of Pacific Edge is that I’d like some shorter term guidance, it would take the volatility out, although it is entirely possible that Pacific Edge could release FY14 sales guidance at any time now given the reporting period is all but up, it’s not uncommon for other companies to do so.
But if one chooses to filter out all the noise, especially that of short term thinkers, here’s pretty much what Pacific Edge have been consistently telling us;
- We are on track for meeting our goal of $100M in revenues by HY18.
- The recent capital raising is for accelerating Cxbladder within the market place.
- Expect Medicare early this year, Intermountain and Kaiser Permanente within 12 mths
- Watch for new markets opening up in Spain and Asia this year.
- We anticipate ‘tens of thousands of sales in 2014’.
It’s a clear message if we choose to listen hard enough.